---
id: legionella-rapid-progression_150
category: radiology
tags: [legionella, rapid-progression, lobar-consolidation, chest-radiology, CT, atypical-pneumonia]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Legionella Pneumonia - Rapid Progression

**Q:** What are the characteristic imaging features of Legionella pneumonia including rapid progression, distribution patterns, and how it differs from typical bacterial pneumonia?

**A:**

## DEFINITION

**Legionella Pneumonia (Legionnaires' Disease):** **"Atypical pneumonia caused by *Legionella pneumophila*, characterized by rapid radiographic progression despite appropriate antibiotics"**

**Key Point:** **Legionella = rapid progression on imaging** (hallmark feature)

---

## KEY IMAGING FEATURE: RAPID PROGRESSION

**Definition:** **"Rapid expansion of infiltrates over 24-72 hours despite antibiotic therapy"**

**Characteristics:**
- **Initial presentation:** Unilateral focal infiltrate
- **24-48 hours:** Progresses to lobar or multilobar consolidation
- **48-72 hours:** Bilateral involvement (30-50%)
- **Progression despite antibiotics** (if not on macrolide/fluoroquinolone)

**Key Point:** **Rapid progression in 24-72 hours = characteristic of Legionella**

---

## CT FINDINGS

**Hallmark: Lobar/Multilobar Consolidation with Rapid Progression**

### **Mnemonic: "RAPID LOBAR"**

**R**apid progression (24-72 hours)
**A**lveolar consolidation (dense opacity)
**P**atchy or lobar (not interstitial)
**I**nfiltrate progression (despite antibiotics initially)
**D**ense opacity (homogeneous consolidation)

**L**obar or multilobar (50-70%)
**O**ften unilateral initially (then bilateral)
**B**ilateral involvement (30-50% eventually)
**A**ir bronchograms (present)
**R**esist typical antibiotics (need macrolide/fluoroquinolone)

**Key Point:** **Lobar consolidation + rapid progression = Legionella**

---

## PATTERN EVOLUTION

**Temporal Progression:**

**Day 1-2:**
- **Focal patchy infiltrate** (unilateral)
- **Single lobe involvement**
- **May resemble typical bacterial pneumonia**

**Day 2-4:**
- **Rapid expansion** to lobar or multilobar
- **Homogeneous consolidation**
- **Air bronchograms**

**Day 4-7:**
- **Bilateral involvement** (30-50%)
- **Multilobar consolidation**
- **Pleural effusion** (30-50%)

**Week 1-2+:**
- **Slow radiographic clearance** (4-8 weeks, slower than S. pneumoniae)
- **May worsen initially** despite appropriate treatment

**Key Point:** **Worsens despite initial antibiotics** (if not covering Legionella)

---

## DISTRIBUTION PATTERNS

**Mnemonic: "BILATERAL LOBAR"**

**B**ilateral (30-50% eventually)
**I**nitially unilateral (70-80%)
**L**obar consolidation (most common pattern)
**A**lveolar (not interstitial)
**T**ypically lower lobes (basilar predominance)
**E**xpansion rapid (24-72 hours)
**R**ight side more common (if unilateral)
**A**ir bronchograms (prominent)
**L**ower lobe predominance

**L**obes involved (multilobar 50-70%)
**O**pacity dense (homogeneous)
**B**asal (lower lobe > upper lobe)
**A**symmetric (if bilateral)
**R**ounds of progression (stepwise worsening)

**Key Point:** **Unilateral → multilobar → bilateral** (progressive involvement)

---

## ASSOCIATED FINDINGS

**Mnemonic: "EFFUSION CAVITATION"**

**E**ffusion (pleural - 30-50%)
**F**ocal consolidation (initially)
**F**luoroquinolone or macrolide needed (treatment)
**U**nilateral initially
**S**low radiographic clearance (4-8 weeks)
**I**nfiltrate progression (rapid)
**O**ften multilobar
**N**odular pattern (less common - 10-20%)

**C**avitation (rare - <5%, immunocompromised)
**A**lveolar pattern (consolidation)
**V**ery rare abscess formation
**I**mmune status normal (usually)
**T**ypical lobar pattern
**A**ir bronchograms
**T**hick consolidation
**I**ndolent clearance (slow)
**O**ccasionally massive effusion
**N**ever clears quickly (weeks)

**Key Point:** **Pleural effusion in 30-50%** (parapneumonic)

---

## LEGIONELLA vs TYPICAL BACTERIAL PNEUMONIA

| **Feature** | **Legionella** | **Typical (S. pneumoniae)** |
|-------------|----------------|------------------------------|
| **Progression** | **Rapid (24-72 hrs)** | Stable or slow progression |
| **Pattern** | **Lobar or multilobar** | Lobar (single lobe) |
| **Bilaterality** | **Bilateral (30-50%)** | Unilateral (usually) |
| **Pleural effusion** | **30-50%** | 10-20% |
| **Cavitation** | **Rare (<5%)** | Rare |
| **Radiographic clearance** | **Slow (4-8 weeks)** | Fast (2-4 weeks) |
| **Response to beta-lactams** | **No** (need macrolide/FQ) | **Yes** |
| **Clinical features** | **GI symptoms, hyponatremia** | **Sudden onset, high fever** |

**Key Point:** **Rapid progression + slow clearance = Legionella**

---

## CLINICAL PRESENTATION

**Classic Triad:**
1. **Pneumonia symptoms** (fever, cough, dyspnea)
2. **Extrapulmonary symptoms** (GI, neurologic, renal)
3. **Hyponatremia** (SIADH)

**Respiratory:**
- **Cough** (initially nonproductive, then productive)
- **Dyspnea**
- **Chest pain** (pleuritic)
- **Hemoptysis** (rare)

**Extrapulmonary:**
- **GI symptoms** (diarrhea 30-50%, nausea, vomiting, abdominal pain)
- **Neurologic** (confusion, headache, ataxia)
- **Renal** (AKI, hematuria)

**Labs:**
- **Hyponatremia** (serum Na <130 - seen in 30-50%)
- **Elevated LFTs** (transaminases)
- **Elevated CK** (rhabdomyolysis)
- **Lymphopenia** (relative)
- **Thrombocytopenia** (mild)

**Key Point:** **Pneumonia + GI symptoms + hyponatremia = Legionella**

---

## RISK FACTORS

**Mnemonic: "LEGIONELLA"**

**L**ung disease (COPD, smoking)
**E**lderly (>50 years)
**G**ouging travel (hotels, cruises, cooling towers)
**I**mmunosuppression (steroids, transplant, biologics)
**O**rgan transplant
**N**eoplasm (hematologic malignancy)
**E**nd-stage renal disease (dialysis)
**L**iving in healthcare facility (nosocomial)
**L**iver disease (cirrhosis)
**A**ge >50 years

**Key Point:** **COPD + smoking + age >50 = highest risk**

---

## DIAGNOSIS

**Urinary Antigen Test (Preferred):**
- **Detects L. pneumophila serogroup 1** (70-80% of cases)
- **Sensitivity:** 70-90%
- **Specificity:** >95%
- **Remains positive** for weeks (even after treatment started)
- **Limitations:** Doesn't detect non-serogroup 1 Legionella

**Culture:**
- **Buffered charcoal yeast extract (BCYE) agar**
- **Slow-growing** (3-5 days)
- **Gold standard** but insensitive (10-30%)

**PCR:**
- **Respiratory specimens** (sputum, BAL)
- **Sensitive and specific**
- **Detects all serotypes**
- **Not widely available**

**Serology:**
- **Not useful acutely** (requires acute + convalescent titers)
- **4-fold rise** in IgG titer (weeks)

**Key Point:** **Urinary antigen = test of choice** (70-90% sensitive, >95% specific)

---

## TREATMENT

**Antibiotics (Cover Intracellular Pathogens):**

**Preferred:**
- **Azithromycin** 500mg IV/PO daily x 5-10 days (first-line) OR
- **Levofloxacin** 750mg IV/PO daily x 5-10 days (alternative)

**Severe (ICU):**
- **Levofloxacin** 750mg IV daily + **azithromycin** 500mg IV daily (combination)
- **Duration:** 7-14 days

**Immunocompromised:**
- **14-21 days** (longer duration)
- **Combination therapy** preferred

**Key Point:** **Macrolide or fluoroquinolone = first-line** (beta-lactams ineffective)

---

## RADIOGRAPHIC CLEARANCE

**Timeline:**
- **Clinical improvement:** 3-5 days (fever resolves)
- **Radiographic improvement:** 7-14 days (begins)
- **Complete clearance:** 4-8 weeks (slower than S. pneumoniae)

**Delayed Clearance:**
- **Immunocompromised** (may take months)
- **Severe disease** (ARDS, multilobar)
- **Smoking** (impaired clearance)

**Key Point:** **Radiographic clearance lags clinical improvement** (weeks to months)

---

## PROGNOSIS

**Overall Mortality:** 5-30% (depends on severity, comorbidities)

**Factors Predicting Poor Outcome:**
- **ARDS** (requires mechanical ventilation)
- **Immunocompromised**
- **Delayed diagnosis** (not started on appropriate antibiotics)
- **Multilobar involvement**
- **Hyponatremia <130**
- **AKI**
- **Age >65 years**

**Key Point:** **ARDS + multilobar + immunocompromised = high mortality** (20-30%)

---

**Clinical Pearls:**
- **Rapid radiographic progression (24-72 hours) = characteristic of Legionella**
- **Unilateral → multilobar → bilateral** (progressive involvement)
- **Lobar or multilobar consolidation** (dense, homogeneous)
- **Pleural effusion in 30-50%** (parapneumonic)
- **Slow radiographic clearance** (4-8 weeks, lags clinical improvement)
- **Pneumonia + GI symptoms + hyponatremia = Legionella**
- **COPD + smoking + age >50 = highest risk**
- **Urinary antigen = test of choice** (70-90% sensitive, >95% specific)
- **Treatment: Azithromycin or levofloxacin** (beta-lactams ineffective)
- **Radiographic worsening despite appropriate treatment initially** (first 24-48 hours)

**Media:**

**Image 1 - Rapid Progression (Legionella):**

*Serial CXRs: (A) Day 1 - focal right lower lobe infiltrate. (B) Day 3 - progression to right middle and lower lobe consolidation. (C) Day 5 - bilateral multilobar involvement despite antibiotics (ceftriaxone + azithromycin). Patient is 65-year-old smoker with COPD. Urinary Legionella antigen positive. Demonstrates characteristic rapid progression.*

**Image 2 - Legionella Pneumonia (CT):**

*CT chest showing dense lobar consolidation of right lower lobe with air bronchograms and moderate pleural effusion. Patient presented with pneumonia, diarrhea, confusion, and hyponatremia (Na 125). Urinary Legionella antigen positive. Treated with levofloxacin, clinical improvement in 4 days but radiographic clearance took 6 weeks.*

**Image 3 - Multilobar Legionella:**

*CT demonstrating bilateral multilobar consolidation (right middle, right lower, left lower lobes). Patient with severe Legionella pneumonia requiring ICU admission. Developed ARDS, required mechanical ventilation. Treated with levofloxacin + azithromycin combination therapy.*

**Additional Resources:**
- **Radiopaedia.org:** Search "Legionella pneumonia," "legionnaires disease"
- **IDSA/ATS CAP Guidelines 2019:** Legionella treatment recommendations
- **CDC:** Legionellosis surveillance and epidemiology

**Sources:** [Radiopaedia - Legionella Pneumonia], [IDSA/ATS CAP Guidelines 2019], [CDC Legionellosis]
